Document is current
Any future updates will be listed below
-
Authors
Chen, Amy Z.
Kumar, Ravinder
Baria, R. K.
Shridhar, Pramod Kumar
Subbaraman, Ramnath
Thies, William
-
Funding
Funding for this research was provided by:
Microsoft Research India
Bill and Melinda Gates Foundation (1154665)
- License Information
-
More Information
Article History
Received: 27 July 2022
Accepted: 22 June 2023
First Online: 31 July 2023
Declarations
:
: This research was conducted in accordance with the Declaration of Helsinki as well as relevant local guidelines and regulations. The study protocol was approved by the Institutional Ethics Committee, Maharishi Markandeshwar Medical College & Hospital, Kumarhatti, Solan, Himachal Pradesh, India (MMMCH/IEC/18/136). Informed consent by people on treatment for TB was waived by this committee, because data was retrieved in de-identified form from programmatic records.
: Not applicable.
: WT co-invented 99DOTS and is a co-founder of Everwell Health Solutions, a company that provides technical support in using 99DOTS to India’s National TB Elimination Program and other organizations globally. AZC was employed at Everwell Health Solutions for a period overlapping the analysis phase of this paper. Neither WT nor AZC received payment from Everwell Health Solutions for time spent on this study. Other authors declare that they have no competing interests.
